Study of Elacytarabine Versus Investigator's Choice in Patients With Late Stage Acute Myeloid Leukaemia (AML)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2010
The purpose of the study is to assess the efficacy and safety of elacytarabine versus investigator\'s choice treatment in patients with relapsed or refractory acute myeloid leukemia (AML).
Epistemonikos ID: 30edcdedf95f5ce8837a149fac0b9191d9bc8039
First added on: Jan 21, 2022